Parametric Portfolio Associates’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$61M Buy
4,256,356
+861,118
+25% +$12.6M 0.03% 499
2021
Q4
$46.3M Sell
3,395,238
-607,917
-15% -$8.53M 0.02% 593
2021
Q3
$65.6M Buy
4,003,155
+230,618
+6% +$3.87M 0.04% 453
2021
Q2
$63.5M Sell
3,772,537
-64,757
-2% -$1.1M 0.04% 473
2021
Q1
$70.1M Buy
3,837,294
+319,168
+9% +$5.74M 0.04% 437
2020
Q4
$64M Sell
3,518,126
-57,379
-2% -$1.01M 0.04% 425
2020
Q3
$63.8M Buy
3,575,505
+81,293
+2% +$1.48M 0.05% 360
2020
Q2
$62.7M Buy
3,494,212
+120,695
+4% +$2.17M 0.05% 343
2020
Q1
$51.2M Sell
3,373,517
-126,470
-4% -$2.29M 0.05% 356
2019
Q4
$69.1M Buy
3,499,987
+341,063
+11% +$6.53M 0.05% 336
2019
Q3
$54.3M Buy
3,158,924
+411,338
+15% +$7.11M 0.04% 394
2019
Q2
$48.6M Sell
2,747,586
-565,410
-17% -$10.3M 0.04% 439
2019
Q1
$67.5M Buy
3,312,996
+1,771,039
+115% +$35.6M 0.06% 303
2018
Q4
$25.9M Buy
+1,541,957
New +$26M 0.03% 649

Other funds holding TAK